The new guidance builds on previous years’ by increasing the focus on transparency and expanding, per statute, to include details about how Medicare Part B drugs and renegotiation processes will be ...
The Biden administration unveiled the next 15 prescription drugs that will be subject to price negotiations between manufacturers and Medicare. It kicks off the second phase of a landmark provision in ...
The Centers for Medicare and Medicaid Services recently announced negotiated prices for 15 drugs, finalizing the second iteration of the Medicare Drug Price Negotiation Program. The first set of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results